Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.WT

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by ProOrbiteon Aug 01, 2017 1:07am
253 Views
Post# 26531956

The reason for the small enrolment of phase 1a

The reason for the small enrolment of phase 1aCant sleep.... Thinking what is at hand here. Found that video I listened to about the Trial size and the reasoning behind it.

Hear RW explain the reason for the small enrolment of phase 1a and phase 1b @ 25.30 of the YouTube video. Based on clinical and statistical significance if your results are dramatic or revolutionary you can get away from a small sample size! They have done that and scored well with Safety and tolerability with the explorability of end point  of efficacy. So far 3 out of 3 @ 30 days NMBIC lession free with cystoscope exam. Remarkable to say the least!
 
https://www.youtube.com/watch?v=3Zz7CkBRDN8&list=PL_XnGk8bWGuwMs9lGkTGaHwAh5TVGw8Ht&index=5
 
 
Also @ 17:30 of the video below RW Anti-cancer Drug preferentially accumulates within the cancer tumor and pre tumerous tissue versus healthy urothelium cells (180 times greater).... Not ADHERED to healthy cells tissue!!!! Just want to make sure pre tumerous is also noted!!
 
Lets be clear here! They want to MIRROR the tremendous success they had in the rat model into the human model! If they do and as so far they have that is Remarkable to say the least!
 
Also Hear RW say “This will be a great success for the organisation and the world ”
QUOTED BY RW @ 18:30 of the video!!!
https://www.youtube.com/watch?v=i3KZ-J8IP1E&index=3&list=PL_XnGk8bWGuwMs9lGkTGaHwAh5TVGw8Ht
 
Also if there is in the future an up list to the NASDAQ then there may be a PP.
If so bring in on but not quite yet!
 
Cheers and good luck to all!

'Cause I'm T.L.D., I'm dynamite        (TLD-1433)
(T.L.D.) and I'll win the fight            (Against cancer)
(T.L.D.) I'm a power load                  (Cancer Koolaid)
(T.L.D.) watch me explode                (Light activated)

(Oi, oi, oi, oi, oi, oi, oi, oi, oi, oi, oi, oi, oi, oi, oi)
Bullboard Posts